Month: 2025-08

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianneng Power International Limited (the “Company”, together with its subsidiaries, collectively referred to as the “Group” or “Tianneng”), (Stock Code: 00819.HK) releases its interim report for the six-month period ended 30 June 2025.In the first half of 2025, adhering to the Group’s vision of Strategic Guidance and Reformation Breakthrough, Tianneng coordinated the three-wheeled strategy of Industry, Technology, and Capital. While solidifying the core competency of the lead-acid battery business, the Group also accelerated the expansion of overseas markets, released the Group’s built-up potential in new-energy battery, deepened the vertical construction of the battery recycle system, and drove the diversification of products and sustainability.Within the reporting period, the Group made a strategic pivot to reduce the trade business, achieved RMB 21.168 billion in revenue for the manufacturing business, which was stable compared to the same period in 2024, accounting for approximately 87.5% of the total revenue within the sector. In terms of the trade business, the Group realized an overall revenue of RMB 30.24 billion, which represented an 89.47% decrease from the same period of 2024. Within The manufacturing sector, the high-end eco-friendly battery business remained stable, providing a resilient financial support for the Group. The emerging businesses experienced significant growth, among which the Li-ion battery business achieved a revenue of RMB 0.501 billion, representing a 174.58% growth from the same period of 2024. Within the reporting period, the Group achieved a gross profit of RMB 2.537 billion, which is stable compared to the same period of 2024. In terms of operating cash flow, the Group achieved RMB 0.891 billion of net inflow, compared to a net outflow of RMB 0.162 billion in the same period of last year. Overall, in the first half of 2025, Tianneng demonstrated strong resilience, developmental momentum, and strategic commitment in a complex external environment.Internationalisation Accelerated, Overseas Expansion Bore FruitsInternational expansion is a vital fulcrum of the Group in strengthening global competitiveness and achieving incremental leaps. In the first half of 2025, the overseas business experienced remarkable growth with continuous positive feedback, achieving a revenue of RMB 0.226 billion, representing a 75.39% growth from the same period of 2024.Within the reporting period, guided by local demands, the Group accelerated its overseas expansion with global industrial resources, and set up operational teams in countries such as Thailand, Vietnam, and Turkey while developing a sales network in major areas including the Asia-Pacific, Europe, North America, the Middle-East and Africa. In addition, the Group’s production base in Vietnam is being constructed in an orderly manner while the capacity of the assembly base is robustly released, laying the groundwork for future developments in the region. The Group has developed customised products based on specific local demands and emphasised building localised operational teams, while advancing its “Overseas Service” strategy, and systematically constructed localised standards. With these developments, the Group was able to optimise its global supply chain and release future growth potentials.Core Business Stable and Resilient, with Promising Growth MomentumWithin the reporting period, the Group pursued a path of “Stability and Growth Duality” under a complex external environment and industrial structure re-balancing. The high-end eco-friendly battery business demonstrated resilience, achieving a revenue of RMB 18.292 billion, providing the vital financial stability for the Group. The high-end eco-friendly batteries are sealed, maintenance-less lead-acid batteries built with the Group’s innovation in design and manufacturing, highly adapting to the demands of the light electric vehicle market, with their cost and performance superiority, are also widely utilised in various fields, including backup power supplies, automobile batteries, and special-purpose industrial power batteries.The Group solidified its competencies in the core business, upgraded its intelligent manufacturing capabilities, improved the operational management system, consolidated its sales network, drove product quality and comprehensive market competitiveness growth, and fortified the resilience of lead-acid batteries in a complex market environment. Within the reporting period, the Group was able to effectively upgrade its manufacturing efficiency and supply-chain resilience through utilising intelligent manufacturing systems and equipment technology upgrades, while demonstrating effective results in cost management. Through the evolution of battery technologies and product upgrades, the Group constructed a differentiated product matrix targeting major fields of usage such as light electric vehicles, data centres, automobile start-stop batteries, and industrial power batteries,driving a service system upgrade with user value at its core, and organically merged the traditional sales network with an innovative digital ecosystem.Solidifying the Diversity of Technological Road-maps and Accelerating New Business Growth In the first half of 2025, the Group committed to the development of new-energy businesses, including Li-ion batteries, solid-state batteries, hydrogen fuel cells, and sodium-ion batteries, and systematically drove innovative breakthroughs, intelligent manufacturing upgrades, user-scenario extensions, and fostered new business growth. The Group’s Li-ion batteries business mainly targets power storage and low-speed power. Within the reporting period, the Group’s power storage and low-speed power business achieved major improvements both in terms of quality and quantity. Specific markets, such as industrial batteries and automobile A/C batteries, also saw improvements in market volume. Overall, the capacity utilisation of the Group’s new-energy business was significantly enhanced, with remarkable improvements in operational efficiency and revenue, RMB 0.501 billion, a 174.58% increase from the same period of 2024.The Group’s solid-state battery also achieved intermittent success within the three dimensions of high energy density, cycle longevity, and high-rate performance. The Group also formed strategic collaborations with industry leaders in the two-wheeled vehicle market and carried out solution testing with partners targeting the low-altitude flying vehicle market. The Group continued its investment in hydrogen fuel-cells with a full-chain R&D system and an expert team, with advanced products, began testing in user-scenarios such as two-wheeled vehicles, public transportation, heavy trucks, and special-purpose machinery, and collaborated with upstream and downstream partners in constructing an application ecosystem. The Group also spearheaded the development and application of sodium-ion battery technology, and conducted experiments for key metrics such as low-temperature and cycle longevity testing for scenarios such as power storage and automobile start-stop battery in a steady manner. Through the multi-roadmap approach, and the “technology breakthrough - user scenario verification - solution delivery” process, the Group’s new-energy business growth is gradually and steadily shifting from individual verification to chain-release, firmly supporting the business momentum.Strengthening the Recycling System and Fortifying Industrial CollaborationThe battery industry is at the core of the Group’s business, which systematically constructed a full-life industry chain of manufacturing, recycling, and reusing, forming a two-railed industry system of lead-acid battery and Li-ion battery, achieving efficient recycling. Within the reporting period, the recycling business of the Group achieved a revenue of RMB 1.8 billion, a 15.82% increase compared to the same period of 2024.As a leader in the recycling industry in China, the Group is continuously building an effective recycling network with front-end reach and back-end efficiency, promoting the efficiency of waste battery recycling empowered by the collaborative effort of businesses at scale, and achieving a top-of-industry recycling ratio of crucial materials. Within the reporting period, the Group continued to enhance the granularity and precision of the recycling process from recycling, processing, and reusing, improve the differentiating system for Li-ion battery recycling, and improve the resource synergies at core regions and user scenarios. Through uninterrupted exploration of technological potential and system performance optimisation, the Group was able to gradually achieve scale advantage and economic value of the recycling system, injecting continuous momentum for the industry.Looking forward, Tianneng will drive industrial upgrades through technological innovation, empower efficient operation through digitisation, rebuild the value-chain system through ecological collaboration, and seek growth through internationalisation. The Group will solidify its competencies in the lead-acid market, accelerate the research, application, and market expansion process of new energy batteries such as Li-ion battery and solid-state battery. The Group will strengthen its capabilities in battery recycling, enhance the collaborative efficiency of industry-chain integration while expediting its expansion into overseas markets and optimising localised operation, from product to service, and develop into a new-energy battery company that is competitive with a global vision. Finally, the Group will promote the convergence between its company values and social values with a growth mindset and build a new paradigm of sustainable and high-quality growth.About Tianneng Power International LimitedTianneng Power International Limited and its subsidiaries (collectively referred to as “Tianneng” or the “Company”), founded in 1986 and headquartered in China, has developed into a leading enterprise in the new energy battery and the light electric vehicle battery industry with a comprehensive manufacturing system and technological advantage. Tianneng was listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 00819. HK) in 2007. After nearly four decades of development, Tianneng has established lead-acid batteries as its core business, focusing on the market of motive batteries for light electric vehicles, while expanding its product in automotive start-stop systems, backup power for communication base stations and other diversified scenarios. The Company is also advancing the R&D, production and sales of lithium-ion batteries, hydrogen fuel cells, sodium-ion batteries and solid-state batteries, offering multi-technology battery solutions for special industrial vehicles, energy storage systems and other applications. Additionally, Tianneng strengthens its recycling economy initiatives around its core operations. Through a dual-track system for lead and lithium recycling, the Company achieves efficient resource regeneration and reuse, building a comprehensive ecosystem for the new energy industry. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月29日 - (亞太商訊 via SeaPRwire.com) – 天能動力國際有限公司(「公司」，連同其附屬公司，統稱「集團或天能」）（股份代號：00819.HK)公布截至2025年6月30日止六個月（「報告期內」）之中期業績。2025年上半年，天能堅持戰略引領、改革破局的總體思路，統籌推進實業、科技、資本三輪驅動戰略。在鞏固鉛蓄電池業務核心競爭力的同時，加速海外市場開拓，推動新能源電池業務從積累轉向釋放，深化電池循環體系的縱深建設，驅動業務全景化、可持續發展。報告期內，集團實施聚焦主業、主動收縮貿易業務戰略，實現制造業營業收入約人民幣211.68億元，較去年同期基本持平，占整體營業收入比例提升至約87.5%；實現貿易業務營業收入約人民幣30.24億元，較去年同期下降約89.47%，占整體營業收入比例下降至約12.50%。製造業中，高端環保電池業務穩築基本盤，為戰略轉型提供堅實的財務後盾。新興業務高速增長，其中，鋰離子電池業務取得營業收入約5.01億元，較去年同期躍升174.58%。報告期內，集團實現毛利額約人民幣25.37億元，較去年同期基本持平；經營現金流釋放躍升，由去年同期約人民幣1.62億元淨現金流出轉變至約人民幣8.91億元淨現金流入。綜上，2025年上半年，在複雜外部環境下，天能展現出強大經營韌性、發展動能和戰略執行力。國際化進程加速 海外市場拓展成果顯著國際化布局是集團提升全球競爭力、實現增量跨越的重要戰略支點。2025年上半年，海外業務呈現突破性增長，市場反饋持續向好，實現營業收入約人民幣2.26億元，較去年同期增長約75.39%。報告期內，集團以當地需求為導向，結合海內外產業資源加速國際市場開拓，於泰國、越南、土耳其等地配置本地運營團隊，發展數十家授權經銷商，銷售網絡覆蓋亞太、歐美、中東非各地區主要國家。越南生產基地建設有序推進，組裝基地產能全面釋放，為區域深耕奠定基礎。針對性開發本地化產品，滿足差異化需求；重點建設本地化渠道與運營團隊；同步推進“服務出海”戰略，系統性構建本地化服務標準體系。優化全球供應鏈，釋放增長動能。主業穩中見韌 蓄勢動能長青 報告期內，集團在複雜外部環境與產業結構再平衡的背景下，堅持「穩中求進，以進促穩」的經營節奏。高端環保電池業務表現堅實，上半年取得營業收入約人民幣182.92億元，為集團穩健續航持續注入動力。高端環保電池是集團基於研發與工藝創新打造的密封型免維護鉛蓄電池，深度適配電動輕型車市場需求，憑借其綜合成本及性能優勢，亦廣泛應用於備用電源、汽車電池與電動特種工業動力電池等領域。集團秉持核心業務優勢，深化智能制造升級、精進運營管理體系、鞏固銷售渠道網絡，驅動產品質量持續提高與綜合市場競爭力不斷增強，強化鉛蓄電池業務在複雜市場環境下的發展韌性。報告期內，集團通過智能制造體系應用與設備技術改造升級，有效提升制造效能與供應鏈保障能力，成本管控成效逐步顯現；依托電池技術迭代驅動產品性能升級，圍繞電動輕型車、數據中心、汽車起動啟停與工業動力等重點場景，形成差異化產品矩陣；驅動以用戶價值為核心的服務體系升級，深度整合傳統經銷網絡與創新數字生態。深化多元技術路線 加快業務增長新動能2025年上半年，集團錨定新能源業務發展方向，圍繞鋰離子電池、固態電池、氫燃料電池、鈉離子電池等多技術路徑，系統推進研發攻關、智能制造與場景拓展，加快培育業務增長新動能。集團鋰離子電池主要聚焦儲能與低速動力等領域。報告期內，集團儲能與低速動力業務實現量的躍升與質的改善，工業電池及駐車空調電池等細分市場增量空間得以拓展，產能利用率明顯提升，整體營收顯著增長，經營質效明顯改善，取得營業收入約5.01億元，較去年同期增長約174.58%。集團固態電池研發取得階段性進展，重點突破高比能、長循環及高倍率三大方向，與頭部兩輪車企業建立戰略合作關系，並在低空飛行器領域與相關企業推進解決方案驗證。集團在氫燃料電池持續投入，擁有全鏈條研發體系和專家團隊，產品性能先進，在兩輪車、公交、重卡及特種機械等場景推進示範驗證，並與上下遊合作夥伴共同構建應用生態。集團同步推進鈉離子電池技術與應用布局，報告期內圍繞汽車起動啟停與儲能等應用場景開展低溫與循環壽命等關鍵指標驗證，保持穩健的產業化節奏。通過多技術路徑的協同，遵循「技術攻堅—場景驗證—方案化交付」的推進節奏，集團新能源電池業務增長動因正由點式驗證向鏈條釋放有序過渡，業務動能得到紮實支撐。夯實循環體系 強化產業協同新動能集團專注於電池產業，系統構建覆蓋生產、回收、再利用的全生命周期產業鏈，形成鉛蓄電池和鋰離子電池雙軌循環產業體系，實現資源高效再生利用。報告期內，集團可循環產業實現對外營業收入約人民幣18.00億元，較去年同期增長約15.82%。作為國內循環產業的領先企業，集團著眼於構建兼具前端觸達能力與後端處理效率的高效回收網絡，以規模化的處置能力和業務協同優勢推動廢舊電池資源有效利用，關鍵材料回收率居於行業前列。報告期內，集團持續貫通回收、處置與再利用全流程，提升鉛蓄電池回收渠道整合力與運營精度；強化鋰離子電池回收差異化路徑布局，深化核心區域與重點場景資源聯動。集團通過深挖技術潛能與優化系統表現，逐步釋放循環體系的規模優勢與經濟價值，為產業注入持久動能。展望未來，天能將以技術革新驅動產業升級，以數智化賦能運營增效，以生態協同重塑價值鏈體系，以全球化布局開拓增量空間，鞏固鉛蓄電池核心主業優勢，加快推進鋰離子電池、固態電池等新能源電池的研發、應用與市場開拓，強化電池回收與資源再生能力，提升產業鏈一體化水平與協同效率。天能將同步加速海外市場布局與本地化經營能力建設，向制造與服務體系延伸，構建發展為具備長期競爭力和全球視野的新能源電池產業格局企業。天能將持續推動企業價值與社會價值深度融合、共同成長，打造可持續、高質量增長的創新範式。關於天能動力國際有限公司天能動力國際有限公司及其附屬公司創立於一九八六年，總部設於中國，憑借完善的制造體系與技術優勢，發展成為新能源電池行業領先企業及輕型電動車電池領域龍頭企業，二零零七年於香港聯合交易所有限公司主板上市（股份代號：00819.HK）。曆經近四十載發展，集團以鉛蓄電池為核心主業，深耕電動輕型車動力電池市場，並拓展至備用電源、汽車電池與工業動力電池等多元領域。集團為全面布局未來新能源生態，在堅守主業優勢的基礎上，積極推進鋰離子電池、固態電池、氫燃料電池及鈉離子電池的研發、生產與銷售，以多技術路線產品矩陣覆蓋多元新能源應用場景，並同步構建循環經濟產業鏈，依托廢舊鉛蓄電池與廢舊鋰離子電池循環利用業務，推動資源高效再生。 Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2025 (the "Reporting Period"). The Group adopted “one horizontal, one vertical” as its core business strategy: horizontally, it extended a lean management system to advance multi-mode collaboration among medical institution alliances; vertically, it focused on specialty-specific innovation in medical diagnostics to fast-track the translation and implementation of new technologies and products. Meanwhile, the Group leveraged AI to enhance the comprehensive solutions for medical institution alliances, promoted the practical application of AI in healthcare scenarios, and continuously strengthened the value of empowering clinical practices, demonstrating strong operational resilience.In the first half of 2025, due to multiple factors, including the centralized drug-procurement program, cost controls of medical insurance, and fierce market competition, the Group’s short-term results did not meet expectations. However, the Group remained committed to product and business model innovation, and further refined the mechanisms and processes of its operational management. By adhering to lean operations, the overall performance has achieved significant improvements. During the Reporting Period, the Group’s gross profit margin reached approximately 34.0%, representing an improvement of approximately 4.4% over the overall gross profit margin for 2024. The net loss amounted to RMB55.4 million, a significant decrease of 56.1% compared to the same period last year. The joint construction business remained the Group’s largest business segment, which recorded the revenue of RMB180.3 million, accounting for 57.6% of the total revenue, increased by approximately 9.6% as compared with the same period last year, achieving significant outcomes in empowering medical alliance clients through in-depth services, paving the way for the Group’s long-term high-quality growth. During the Reporting Period, the Group’s diagnostic testing services recorded revenue of RMB313.2 millionSteadily implementing “one horizontal, one vertical” strategy, with notable achievements in hospital-enterprise partnerships“One horizontal” ——Extending lean management system to deepen diverse forms of collaboration within medical institution alliancesYunkang has been committed to developing an innovative service mode for the joint construction of medical institution alliances featuring “professionalism as the foundation, standardization as the core, digital intelligence as the means, synergization as the goal”. During the Reporting Period, the Group provided nearly 450 alliance clients with multi-scenario solutions tailored to different clinical needs, including AI+ digital intelligence solutions for medical institution alliances, comprehensive collaborations with medical laboratories, solutions for regional/pathology centers and precision medicine center, and specialty-based solutions for alliance development, among other multi-model collaboration services. By leveraging Yunkang’s strengths, the Group assisted healthcare institutions at all levels in enhancing service capabilities and expanding service coverage, established a hierarchical and coordinated healthcare service system, and promoted the development of regional hierarchical diagnosis and treatment services.During the Reporting Period, despite increasingly fierce market competition, the Group maintained solid growth in the joint construction business through continuous deep collaboration with leading hospitals and municipal and county-level hospitals, further consolidating its competitive advantage.“One vertical” ——Joint innovation platform for diagnostic testing serves as strong driver for R&DThe Group has always focused on “clinical needs”, continuously strengthening hospital-enterprise collaboration and pioneering the establishment of a joint innovation platform for diagnostic testing, driving business expansion and product competitiveness. During the Reporting Period, the Group forged joint diagnostic innovation partnerships with dozens of top-tier medical institutions nationwide, delivering a portfolio of testing products addressing multiple infectious syndromes, including respiratory tract infections, central nervous system infections, urinary tract infections, gynecological infections, and tuberculosis, as well as genetic testing products for personalized medication. Collectively, these innovative products have served nearly 300 clients across the country, and achieved sustained growth in testing revenue.During the Reporting Period, Yunkang and Guangdong Provincial People’s Hospital successively launched a series of new panel products covering respiratory tract infections, central nervous system infections, and invasive fungal infections, successfully creating a standardized incubation model for domestic hospital-enterprise research innovation and translation, as well as a “1+N” medical inspection collaboration network. Moreover, throughout the process of scientific and technological innovation, both parties have gained rich clinical experience. With the active involvement and sustained efforts of dozens of domestic diagnostic experts and scholars, they formulated the Expert Consensus on the Application of tNGS for Clinical Standardization, which was published during the Reporting Period in Chinese Journal of Laboratory Medicine, a leading journal in China’s diagnostic field. During the Reporting Period, Yunkang also maintained close collaboration with the First Affiliated Hospital of Guangzhou Medical University, one of China’s top-tier hospitals, and successfully developed a urinary tNGS product, advancing the clinical practice of precision diagnosis and treatment for urinary tract infections. Simultaneously, Yunkang partnered with the First Affiliated Hospital of Jinan University to establish a “university-hospital-enterprise joint innovation platform” and incubated and operated the “innovation project of psychiatric drug genetic testing”, which has successfully yielded genetic testing products for antidepressants, anti-anxiety drugs, and sedative-hypnotics.AI empowers multi-modal solutions for medical institution alliances, improving quality and efficiency to deepen client services During the Reporting Period, Yunkang fully employed DeepSeek and achieved digital deployment across its platforms. Centered on the core concepts of “AI+” and “precision diagnostics”, Yunkang extensively applied artificial intelligence technology across the multi-technology platforms of its medical laboratories. Taking the in-depth integration of AI technology with Yunkang pathology diagnosis platform as an example, the per-slide efficiency of AI-empowered diagnostic was continuously optimized, achieving simultaneous improvements in intelligence, efficiency, and quality. Moreover, through the deployment of intelligent applications, Yunkang realized smart online customer services and the efficient review of results and reports, which fully streamlined diagnostic service processes and improved experience and satisfaction of its client services. In the process of jointly developing new technologies and products through hospital-enterprise R&D, Yunkang’s AI technology empowered product innovation and R&D across multiple aspects, including bioinformatics analysis, report interpretation, disease risk assessment, and development and translation of novel products, by leveraging the powerful data analysis, modeling, and predictive capabilities of large-scale AI models. This has accelerated the clinical implementation.Notably, Yunkang unveiled its medical AI model “ZhiYun” developed in collaboration with Runda Medical and Huawei, spanning the entire clinical workflow from pre-diagnosis to diagnosis and post-diagnosis. It will provide more efficient and convenient support and experience across all stages of clinical medical services. Meanwhile, Yunkang signed a strategic cooperation agreement with Runda Medical to strengthen in-depth collaboration across the industrial ecosystems in “AI + IVD + healthcare services”, jointly promoting the development and application of large-scale AI models in the medical field, and providing clients with digital-intelligence healthcare solutions. In the future, “ZhiYun”, the medical AI model, will be piloted in Yunkang’s healthcare partners and gradually rolled out nationwide, to improve quality and efficiency of medical institution alliance operations.Future prospects2025 marks the final lap for implementing the 14th Five-Year Plan. China has accelerated the capacity expansion of premium healthcare resources and their extension to lower-tier markets, resulting in a more balanced regional distribution. The country has also expedited the development of medical institution alliances and driven their upgrade from “framework building” to “high-quality operation”. Clinical treatment is also shifting from “broad-spectrum therapies” to “precision medicine”, with the growth potential of the industry continuing to be realized. At the same time, AI technology has continued to empower hierarchical diagnosis and treatment services, and the industry is embracing new growth opportunities. Looking ahead, Yunkang will continue to keep pace with industry development trends and align with national policies, further strengthening the value of empowering clinical practices, and persistently exploring the “product innovation + business innovation” dual-pronged model to accelerate business development, deeply empower medical testing services, and benefit more residents.Yunkang Group Limited (Stock Code: 2325)Yunkang Group is a leading medical operation service provider in China, which started to provide standardized medical diagnostic services to medical institutions at all levels as early as 2008. Leveraging its own professional diagnostic capabilities and the nationwide service network of integrated healthcare systems, Yunkang has gradually grown to become a medical operation service platform. Meanwhile, Yunkang is a medical operation service provider in China offering a full suite of diagnostic testing services which are diagnostic outsourcing services and diagnostic testing services for medical institution alliances. Yunkang provides diagnostic services through on-site diagnostic centers to collaborative hospitals in the integrated healthcare systems in China and assists them in improving their clinical diagnosis capabilities through co-developing diagnostic centers. As of today, Yunkang has successfully provided professional services to nearly 450 on-site diagnostic centers. As of June 30, 2025, the hospitals we collaborated with were located across 31 provinces and municipalities in China. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月29日 - (亞太商訊 via SeaPRwire.com) – 領先的中國醫學運營服務供應商雲康集團有限公司（「雲康」或「集團」；股份代號：2325）公佈截至2025年6月30日止（「報告期」）之中期業績。集團以「一橫一縱」為主要經營策略，橫向輸出精益運營體系，推進醫聯體多模式合作，縱向聚焦專科方向上的醫檢聯合創新，加速新技術新產品轉化及應用推廣，同時以AI賦能醫聯體整體解決方案，推動AI在醫療場景的實際應用，持續強化臨床賦能價值，呈現強大的經營韌性。2025年上半年，受集採、醫保控費及行業競爭加劇等多方面因素影響，導致集團短期業績未達預期，然而集團始終堅持產品創新和模式創新，並進一步完善企業經營管理的機制和流程，堅持精益運營，整體經營取得明顯成效。報告期內，集團毛利率約為34.0%，較2024年度整體毛利率提升約4.4%；虧損淨額人民幣55.4百萬元，較上年同期減少56.1%，明顯收窄。此外，醫聯體共建業務板塊持續為集團第一大業務板塊，錄得收益人民幣180.3百萬元，佔總收益的57.6%，較上年同期提升約9.6%，在深度服務賦能醫聯體客戶方面成效顯著，為集團長期高質量發展奠定基礎。報告期內，集團診斷檢測服務錄得收益人民幣313.2百萬元。一橫一縱策略穩步實施，院企合作成效明顯「一橫」——輸出精益運營體系，深化醫聯體多模式合作雲康一直致力於發展「以專業化為基礎、標準化為核心、數智化為手段、協同化為目標」的醫聯體共建創新服務模式。報告期內，集團已為近450家醫聯體客戶提供不同臨床需求的多場景解決方案，包括AI+醫聯體數智化解決方案、醫學實驗室整體合作、區域╱病理中心解決方案、精準醫學中心解決方案、專科聯盟建設解決方案等多模式合作。透過發揮雲康優勢，協助各級醫療機構提升服務能力、外拓服務範圍，構建分級協同的醫療服務體系，促進區域分級診療發展。報告期內，雲康持續與頭部引領型醫院、各地區市縣級醫院展開深度合作，在市場競爭形勢日趨嚴峻的情況下，醫聯體共建業務板塊仍保持穩健發展，競爭優勢進一步鞏固。「一纵」——醫檢聯合創新平台打造科研創新強引擎集團始終聚焦「臨床需求」，不斷加強院企合作，首創性打造「醫檢聯合創新平台」，助力集團業務開拓及提升產品競爭力。報告期內，集團已與全國數十家頂級醫療機構開展醫檢聯合創新合作，累計成功開發出數十項針對呼吸道感染、中樞神經系統感染、泌尿系統感染、婦科感染、結核感染等多領域的不同感染症候群檢測產品，以及個性化用藥基因檢測產品，創新產品累計服務客戶近300家，檢測收益持續增長。報告期內，雲康與廣東省人民醫院先後上市呼吸道感染、中樞神經感染、侵襲性真菌感染等系列新panel產品，成功構建國內院企科研創新轉化標準化孵育模式和「1+N」醫檢協同網絡，此外，雙方在科研創新過程中，積累了豐富的臨床經驗，在數十位國內臨床、檢驗等多領域專家學者的積極參與和持續推動下，形成了《tNGS臨床規範化應用專家共識》，並於報告期內在國內檢驗頂級期刊《中華檢驗醫學雜誌》發佈。報告期內，雲康亦與國內頂尖醫院廣州醫科大學附屬第一醫院緊密合作，成功開發泌尿tNGS產品，推動尿路感染精準診療的臨床實踐。同時，雲康與暨南大學附屬第一醫院聯合打造「校院企聯合創新平台」，孵化和運營「精神疾病藥物基因檢測創新項目」，並成功開發出抗抑鬱藥物基因檢測、抗焦慮及鎮靜安眠藥物基因檢測產品。AI賦能醫聯體多模式解決方案，提質增效深化客戶服務報告期內，雲康全面接入DeepSeek，實現集團數字化平台部署。雲康以「AI+」與「精準診斷」為核心理念，將人工智能技術廣泛應用於旗下醫學實驗室的多技術平台。以AI技術與雲康病理診斷平台的深度融合為例，雲康病理檢測流程被極大壓縮，單切片AI診斷效率持續優化，實現智能、效率、質量三重提升。此外，透過部署智能化功能應用，雲康已實現智能在線客服、結果與報告高效審核等功能，全面優化醫檢服務的流程，提升客戶服務體驗和滿意度。在院企聯合研發新技術新產品過程中，借助AI大模型強大的數據分析、模型構建和智能預測能力，雲康AI技術從生信分析、報告解讀、疾病風險評估、創新產品研發轉化等多方面賦能產品創新研發，加速產品落地臨床。值得一提的是，雲康攜手潤達醫療、華為共同開發的醫療大模型「智雲」已重磅發佈，覆蓋了診前、診中、診後的全流程場景，將為臨床醫療服務全流程提供更加高效、便捷的支持和體驗。同時，雲康與潤達醫療簽署戰略合作協議，以強化「AI+IVD+醫療服務」在產業生態鏈之間的深度合作，並共同推動人工智能大模型在醫療端的發展與應用，為客戶提供數智化的醫療解決方案。未來，「智雲」醫療大模型將在雲康合作醫療機構中試點應用，並逐步推廣至全國，為醫聯體建設運營提質增效。未來展望2025年是「十四五」規劃的收官之年，國家推動優質醫療資源加快擴容下沉，促進區域佈局更加均衡，同時不斷加快醫聯體建設，推動其由「搭框架」向「高質量運營」升級。臨床治療亦正從「廣譜治療」邁向「精準化治療」新階段，行業增長潛力持續釋放。同時，AI技術持續賦能分級診療，行業將迎來發展新機遇。展望未來，雲康將繼續緊跟行業發展脈搏，以國家政策為導向，不斷強化臨床賦能價值，持續探索「產品創新+模式創新」雙輪模式，加速業務開拓，深度賦能醫學檢測服務，惠及更多居民。雲康集團有限公司（股份代號：2325）雲康集團是中國領先的醫學運營服務提供商，早於2008年雲康便開始面向各級醫療機構提供標準化的醫療診斷服務，透過利用自身專業的診斷能力以及覆蓋全國的醫聯體服務網絡，逐漸發展成為醫學運營服務的領先平台。雲康也是中國領先的醫聯體診斷服務供應商，提供涵蓋醫聯體診斷及診斷外包的全方位醫療健康服務。雲康向中國醫聯體內的合作醫院提供診斷檢測服務，透過現場診斷中心協助其提升臨床診斷能力。迄今為止，雲康已成功為來自全國近450家現場診斷中心提供專業服務，截至2025年6月30日，雲康合作的醫院分佈於中國31個省市。 Copyright 2025 亞太商訊 via SeaPRwire.com.

Toronto, ON, August 28, 2025 - (ACN Newswire via SeaPRwire.com) - Digital Shovel, a leading innovator in crypto mining infrastructure solutions, is thrilled to announce the successful completion of its partnership with IREN (formerly Iris Energy Limited), marked by the delivery of the final batch totaling 493 MW of busway sets, including active units and spares. This milestone, achieved well ahead of schedule, underscores Digital Shovel’s commitment to excellence and reliability in supporting next-generation data center operations.The partnership, formalized in February 2024, saw Digital Shovel supply IREN with almost 500 MW of busways, critical to powering IREN’s expanding data centers, which are optimized for Bitcoin mining and AI cloud services using 100% renewable energy. The project was completed without delays, with deliveries consistently surpassing expectations, enabling IREN to advance its operational timeline.“We are incredibly proud of the seamless execution of this partnership with IREN,” said Scot Johnson, CEO of Digital Shovel. “Delivering all 493 MW of busway sets ahead of schedule is a testament to our team’s dedication and the strength of our innovative solutions. IREN’s vision for sustainable, high-performance data centers aligns perfectly with our mission, and we’re excited about the impact this project will have on their growth.”The early completion of this contract also positions both companies for future collaboration. “This project has been a fantastic opportunity to showcase what we can achieve together,” Johnson added. “We’re eager to explore new ventures with IREN as they continue to lead in renewable energy-powered data centers for Bitcoin mining and AI applications.”The success of this deployment lays the foundation for expanded collaboration as demand for infrastructure solutions continues to surge. With proven capacity to deliver at scale and speed, Digital Shovel is positioned to help power the next generation of energy-efficient data centers across North America.For more information about Digital Shovel and its solutions, please visit www.digitalshovel.com.About Digital ShovelDigital Shovel is a leading vertically integrated HPC, AI and Bitcoin Mining systems manufacturer, building critical elements for datacenter construction. This includes turnkey modular datacenters, as well as infrastructure including switchgear, Smart PDUs, busway systems and more. For more info, visit www.DigitalShovel.com About IRENIREN (NASDAQ: IREN), formerly Iris Energy Limited, is an Australia-based company operating next-generation data centers powered by 100% renewable energy. With facilities optimized for Bitcoin mining, AI cloud services, and other power-dense computing applications, IREN is a global leader in sustainable, high-performance data center solutions. For more information, visit www.iren.com.Media Contact:Press@DigitalShovel.comhttps://www.digitalshovel.com Copyright 2025 ACN Newswire via SeaPRwire.com.

SINGAPORE, Aug 27, 2025 - (ACN Newswire via SeaPRwire.com) - TechInnovation® 2025, Singapore’s preeminent platform for innovation and business transformation, returns for its 13th edition from 29–31 October 2025 at Sands Expo & Convention Centre, Level 3 Heliconia and Hibiscus Ballroom, Singapore. Organised by IPI Singapore, the three-day event will bring together over 40 expert speakers, more than 100 breakthrough technologies and curated programmes designed to accelerate real-world innovation and cross-border collaboration.Building on last year’s momentum, which brought together more than 100 exhibitors from 8 countries, attracted attendees from 42 markets, and resulted in over 30 projects supported by IPI Singapore after the event, TechInnovation 2025 will once again convene innovators, startups, corporates, and government agencies across Asia to showcase emerging technology solutions and forge strategic partnerships. In 2024, notably, 46 percent of visitors were senior management decision-makers, underscoring the event’s position as a high-value marketplace for business and technology leaders.The event focuses on sectors including smart buildings, urban solutions, engineering, digital health, sustainability, advanced manufacturing and AI, ensuring businesses can find solutions tailored to their growth ambitions while engaging directly with innovation leaders, potential collaborators and funding partners. Anchored on the theme Discover, Connect and Collaborate, TechInnovation 2025 offers exhibitors and visitors a platform to showcase ready-to-market technologies, connect with potential partners across borders, and co-create solutions to address real-world challenges faced by businesses.Innovation in Action: Interactive BoothsDebuting this year, TechInnovation 2025 will feature experiential technology showcases, giving select exhibitors the chance to showcase their ready-to-market technologies in a hands-on, interactive format. These interactive spaces are designed to spark conversations, encourage engagements and foster meaningful connections across the show floor. For SMEs, the booths offer a unique opportunity to showcase innovations, build credibility and connect directly with potential partners and customers. The launch responds to strong demand for immersive, real-world demonstrations that make technology tangible and memorable.Call for ExhibitorsTechInnovation 2025 invites technology providers, research institutions, startups and solution developers to participate as exhibitors. Exhibitors will benefit from exposure to thousands of decision-makers and industry leaders, targeted business matching opportunities and media visibility through IPI Singapore’s pre-event publicity and digital campaigns.“TechInnovation brings together enterprises and partners to explore new ideas,” said Michael Goh, Chief Operating Officer of IPI Singapore. “We look forward to welcoming exhibitors whose innovations can support practical business applications and contribute to a more sustainable and competitive future.”About TechInnovation 2025Returning for its 13th edition, TechInnovation 2025 is the flagship event of IPI Singapore, connecting technology seekers and providers across Asia. The event serves as a dynamic marketplace for co-innovation and tech adoption, drawing participation from startups, SMEs, corporates, universities and government agencies.This year’s theme, “Discover, Connect, Collaborate” underscores TechInnovation’s mission to drive growth through discovery, global connection and collaboration. The event will feature over 40 speakers, more than 100 technologies and 3 days of programming designed to scale real-world business innovation. TechInnovation is organised by IPI Singapore, a subsidiary of Enterprise Singapore and catalyst of Singapore’s open innovation ecosystem.TechInnovation® is a registered trademark of IPI Singapore.Learn more at www.techinnovation.com.sg.About IPI SingaporeIPI Singapore is an innovation catalyst that creates opportunities for enterprises to grow beyond boundaries. As a subsidiary of Enterprise Singapore, IPI Singapore accelerates the innovation process of enterprises through access to its global innovation ecosystem and advisory services.With a strong belief that innovation is key to enterprise growth, IPI Singapore provides enterprises with access to innovative ideas and technologies. IPI Singapore also facilitates and supports enterprises' innovation processes, including commercialisation and go-to-market strategies.Learn more at https://www.ipi-singapore.org/Media Contact:Sheree TanManager, Marketing & Communications, PartnershipsIPI Singapore ipi_comms@ipi-singapore.orgTheodore WoonDirectorPINPOINT PR Pte. Ltd.theodore@pinpointpr.global Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - On August 27, CALB Group Co., Ltd. ("CALB" or "the Company," stock code: 3931.HK) announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025 (the "Reporting Period"). During the Reporting Period, the Company delivered outstanding operational performance with revenue of RMB16,418.88 million, representing an increase of 31.7% compared to the same period last year, and realized a profit of RMB752.99 million, representing a year-on-year increase of 80.4%. In the first half of 2025, the Company showed strong profitability and resilience during the accelerated trend of transformation of global renewable energy development.According to SNE Research, the Company’s installed capacity of globally EV batteries in the first half of 2025 increased 22.7%, ranking third domestically and fourth globally, with the monthly installed capacity reaching 4.7GWh. The Company was particularly outstanding in the domestic passenger vehicle market with the market share hitting new highs in June and July, reaching 7.4% and 8.25%, respectively. In the energy storage sector, the Company's growth was even more rapid. According to InfoLink, the Company’s shipment in the first half of the year ranked fourth globally, achieving milestone development in the energy storage sector.Centered on continuous technological breakthroughs and with the launch of multiple major products, in the first half of 2025, the Company maintained its leadership in cutting-edge battery technology with the “UP” battery. At the same time, the Company’s 400Wh/kg solid-liquid hybrid battery is poised for mass production and commercial deployment, while significant progress has been made in the all-solid-state battery—including breakthroughs in R&D and the commissioning of a dedicated production line. CALB’s high-power lithium iron phosphate R46 large cylindrical battery is the first in the industry to achieve mass production and has successfully achieved mass production for the latest PHEV models from Geely and Dongfeng. At the same time, the Company’s next-generation lithium manganese LFP battery product achieves an energy density exceeding 210Wh/kg and will also go into mass production. With improved performance, the product can attain 10%- 80% charging within 15 minutes.In the passenger vehicle market, leveraging exceptional product capabilities, the Company achieved full entry into the world’s top three automakers, namely Volkswagen, Hyundai and Toyota. In the first half of 2025, its 800V 5C batteries achieved a monthly sales volume of over 20,000 packs, which will support models for XPeng, Ledao, Leapmotor, Audi, BAIC, and others, and the 800V 5C high-voltage NCM battery exclusively supports popular models such as XPeng’s new P7 with ultra-long range, helping XPeng’s new P7 create a new world record of driving 3,971km in 24 hours.In the commercial vehicle market, CALB has established a comprehensive product matrix architecture for “ZHIYUAN” batteries, covering all scenarios, all applications, and all capabilities. In the first half of year, the Company’s domestic commercial vehicle installed capacity has increased by 310% year-on-year. CALB is the first in the industry to launch a million-kilometer customized products for light trucks, significantly improving the quality assurance of battery systems and effectively enhancing product competitiveness in the market. Leveraging the outstanding recognition from the light truck field, the Company has established in-depth collaborations with customers such as Chery, Geely, Ruichi, Foton, Dongfeng, Changan, and King Long. In the heavy truck field, the Company has deeply cultivated the market through the scenario-based power consumption design and has achieved full-spectrum collaboration by partnering with customers such as Sinotruk, XCMG, SANY, Shaanxi Automobile, Jiefang, Dongfeng, Lingong, and Liugong.The Company has made significant breakthroughs in the international market, and its energy storage business achieved rapid growth in the first half of year. The 314Ah second-generation long-cycle energy storage cell can achieve an ultra-long service life of 15,000 cycles and high energy efficiency of over 96%, while achieving zero degradation in the first 1,000 cycles, earning high recognition from customers for both the product and delivery capabilities. In terms of the overseas market, the Company has successfully partnered with the largest power plant projects in Latin America and South Africa, entering the supplier lists of several leading developers and power grid companies. Meanwhile, the Company’s next-generation “ZHIJIU” of 588Ah and 600Ah+ large energy storage cells will scheduled for mass production within the year.In addition, the Company is the first in the industry to pass the eVTOL power battery manufacturing compliance review and supports the development of China’s low-altitude economy market by actively exploring emerging markets. At present, the R46 cylindrical battery cell with an energy density of 310Wh/kg is now in mass production for leading eVTOL customers in the industry. At the same time, CALB signed a deepened strategic cooperation agreement with GOVY, under which the two parties will carry out in-depth collaboration in the eVTOL sector and jointly promote the development of standardized eVTOL energy products.Overall, in the first half of the year, CALB focused on the strategy of consolidating its leadership in products and technologies, while accelerating the globalization of its production capacity layout. At present, its battery Pack plant in Thailand has been put into operation, while construction of the Portugal base officially commenced in the first quarter of 2025. Looking ahead, with the further improvement of industrial chain system, the Company is expected to leverage its cross-domain, cross-scenario dynamic storage product matrix to achieve deep synergy in its dynamic storage business, creating cutting-edge product capabilities across all scenarios. At the same time, the Company will continuously explore emerging markets such as rail transit, mining, low-altitude flight, and humanoid robots by offering high-safety, high-reliability, and high-performance product solutions. Furthermore, CALB will continue to advance the implementation of its “energy+” strategy, further consolidating its leading position in the global new energy industry.About CALBCALB is a new energy enterprise specializing in the research, production, sales, and market application development of lithium batteries, battery management systems, and related integrated products and lithium battery materials. As Battery Expert, we aim to build a comprehensive energy operation system, to provide complete product solutions and full life-cycle management for the new energy application market, represented by power and energy storage.Currently, CALB has completed an all-round layout in domestic by setting up industrial bases in Changzhou, Xiamen, Wuhan, Chengdu, Hefei, Jiangmen and Meishan. Meanwhile, CALB has set up bases in Europe and ASEAN, vigorously expanding the layout all over the world to become a global leading enterprise with large-scale intelligent manufacturing capabilities. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月28日 - (亞太商訊 via SeaPRwire.com) - 8月27日，中創新航科技集團股份有限公司（「中創新航」或「公司」，股票代碼：3931.HK），公佈截至2025年6月30日止六個月（「報告期」）的未經審計簡明合併中期業績。報告顯示，上半年公司經營表現亮眼，實現營業收入人民幣16,418.88百萬元，較上年同期顯著增長31.7%；期內利潤實現人民幣752.99百萬元，同比大幅增長80.4%，在全球可再生能源發展加速轉型的態勢中展現出強勁的盈利能力與發展韌性。根據權威機構SNE Research統計，中創新航2025年上半年全球動力電池裝車量同比增長22.7%，排名穩居國內第三、全球第四，單月裝車量已達4.7GWh。在國內乘用車市場，公司表現尤為突出，6月、7月市占率連續創下新高，分別達到7.4%和8.25%。儲能領域增速更為迅猛，InfoLink資料顯示，公司上半年儲能電芯出貨量躍升至全球前四，實現里程碑式發展。支撐這一系列成績的，是中創新航技術的持續突破和多款重磅產品的量產落地。上半年，中創新航攜「頂流」電池持續引領技術前沿，公司400Wh/kg固液混合電池產品即將量產配套，全固態電池研發取得突破、生產線貫通投用。此外，公司高功率磷酸鐵鋰R46大圓柱電池實現行業內首家量產配套，成功助力吉利、東風最新混動車型；而下一代210Wh/kg以上能量密度磷酸錳鐵鋰電池產品也即將批量應用，該產品可實現10%電量至80%電量充電時間15分鐘，產品性能進一步提升。在乘用車市場，憑藉卓越的產品實力，中創新航成功實現大眾、現代、豐田全球前三大車企集團全部進入。上半年，其800V 5C電池實現月銷量超2萬台，順利推進配套小鵬、樂道、零跑、奧迪、北汽等多個車型，該超充電池三元版本獨家配套全新小鵬P7，並助力其創下24小時行駛3971公里的全球紀錄。在商用車領域，中創新航構建至遠電池全場景、全覆蓋、全賦能的產品矩陣架構，上半年國內商用車裝車量同比增長310%。公司行業首推輕卡車型百萬公里定製版，大幅提升電池系統質保，獲得業內廣泛認可，目前已與奇瑞、吉利、瑞馳、福田、東風、長安、金龍等知名企業深度合作。在重商領域，公司以場景化電量設計深耕市場，與重汽、徐工、三一、陝汽、解放、東風、臨工、柳工等客戶在多方面達成全方位合作。伴隨著國際市場的重大突破，中創新航上半年儲能業務發展迅猛。其314Ah二代長迴圈儲能電芯憑藉96%以上的能效、15,000次的超長壽命、前1,000次迴圈零衰減的卓越性能獲得國內國際客戶的高度認可，並成功斬獲拉美和南非最大電站專案，進入多家頭部開發商和電網公司的供應商名錄。另外，公司新一代「至久」588Ah、600Ah+儲能大電芯亦將於今年量產。除此之外，作為行業首家通過eVTOL動力電池製造符合性審查的企業，中創新航大力探索新興市場，助力我國低空經濟發展。目前，公司310Wh/kg的R46圓柱電芯已量產配套行業頭部eVTOL企業。同時，中創新航已與廣汽高域簽署深化戰略合作協定，約定在eVTOL領域展開深入合作，共同推進eVTOL電源標準化產品的發展。整體來看，中創新航上半年圍繞「產品與技術領先」戰略，加速全球化產能佈局。目前，泰國Pack工廠已穩定交付，且葡萄牙基地也已於2025年一季度破土動工，未來隨著其產業鏈佈局的進一步完善，中創新航有望憑藉跨領域、跨場景的動儲產品矩陣，實現動儲業務深度協同，全場景打造硬核產品力，同時，持續開拓軌道交通、礦山礦用、低空飛行、人形機器人等新興市場，持續推進「能源+」戰略落地，進一步推進在全球新能源產業中的領先地位。關於中創新航集團有限公司中創新航（3931.HK）是專業從事鋰電池、電池管理系統及相關整合式產品和鋰電池材料的研製、生產、銷售和市場應用開發的新能源高科技企業。作為電池專家，公司致力於構建全方位能源運營體系，為以動力及儲能為代表的新能源全場景應用市場提供完善的產品解決方案和全生命週期管理。目前，公司已建立江蘇、福建、四川、湖北、安徽、廣東等多個產業基地，完成全方位國內產業佈局，同時已設立歐洲產業基地、泰國產業基地，大力拓展海外產業佈局，打造擁有規模化智慧製造實力的國際化領先企業。 Copyright 2025 亞太商訊 via SeaPRwire.com.